William Blair analyst, Raju Prasad, reiterated his Outperform rating on shares of Krystal Biotech (NASDAQ: KRYS) after meeting with management ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE